Cargando…

Multiple sclerosis: getting personal with induced pluripotent stem cells

Mostrar otras versiones (1)

Human induced pluripotent stem (iPS) cells can be derived from lineage-restricted cells and represent an important tool to develop novel patient-specific cell therapies and research models for inherited and acquired diseases. Recently, patient-derived iPS cells, containing donor genetic background,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Ruscio, A, Patti, F, Welner, R S, Tenen, D G, Amabile, G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650727/ https://www.ncbi.nlm.nih.gov/pubmed/26158512 http://dx.doi.org/10.1038/cddis.2015.179

Ejemplares similares

Multiple sclerosis: getting personal with induced pluripotent stem cells
por: Di Ruscio, A, et al.
Publicado: (2016)

Induced pluripotent stem cells in hematology: current and future applications
por: Focosi, D, et al.
Publicado: (2014)

Mesenchymal Stem Cells and Induced Pluripotent Stem Cells as Therapies for Multiple Sclerosis
por: Xiao, Juan, et al.
Publicado: (2015)

Application of Induced Pluripotent Stem Cell Technology to the Study of Hematological Diseases
por: Li, Mailin, et al.
Publicado: (2017)

Induced Pluripotent Stem Cell-Derived Red Blood Cells and Platelet Concentrates: From Bench to Bedside
por: Focosi, Daniele, et al.
Publicado: (2017)

Dissecting the role of aberrant DNA methylation in human leukemia
por: Amabile, Giovanni, et al.
Publicado: (2015)

Response to NK cell content does not seem to influence engraftment in ex vivo T cell depleted haploidentical stem cell transplantation
por: Lobo de Figueiredo-Pontes, Lorena, et al.
Publicado: (2022)

Getting closer to modeling the gut-brain axis using induced pluripotent stem cells
por: Hall, Vanessa, et al.
Publicado: (2023)

Induced Pluripotent Stem Cells and Their Applications in Amyotrophic Lateral Sclerosis
por: Du, Hongmei, et al.
Publicado: (2023)

Human Induced Pluripotent Stem Cell-Derived Astrocytes Are Differentially Activated by Multiple Sclerosis-Associated Cytokines
por: Perriot, Sylvain, et al.
Publicado: (2018)

Transcriptional abnormalities in induced pluripotent stem cell-derived oligodendrocytes of individuals with primary progressive multiple sclerosis
por: Plastini, Melanie J., et al.
Publicado: (2022)

Efficient Generation of Myelinating Oligodendrocytes from Primary Progressive Multiple Sclerosis Patients by Induced Pluripotent Stem Cells
por: Douvaras, Panagiotis, et al.
Publicado: (2014)

Multiple Sclerosis Patient-Specific Primary Neurons Differentiated from Urinary Renal Epithelial Cells via Induced Pluripotent Stem Cells
por: Massa, Megan G., et al.
Publicado: (2016)

Commentary: When the going gets… stuck
por: Amabile, Andrea, et al.
Publicado: (2021)

Pluripotency of induced pluripotent stem cells
por: Kang, Lan, et al.
Publicado: (2012)

Pluripotency of Induced Pluripotent Stem Cells
por: Feng, Chunjing, et al.
Publicado: (2013)

Myths and Misconceptions around Antibiotic Resistance: Time to Get Rid of Them
por: Amábile-Cuevas, Carlos F.
Publicado: (2022)

SALL4: An Intriguing Therapeutic Target in Cancer Treatment
por: Moein, Shiva, et al.
Publicado: (2022)

Induced pluripotent stem cells are induced pluripotent stem cell-like cells
por: Song, Liting, et al.
Publicado: (2015)

Epigenetic Features of Human Perinatal Stem Cells Redefine Their Stemness Potential
por: Gaggi, Giulia, et al.
Publicado: (2020)

Induced pluripotent stem cells and personalized medicine: current progress and future perspectives
por: Chun, Yong Soon, et al.
Publicado: (2011)

Treatment of Parkinson’s Disease through Personalized Medicine and Induced Pluripotent Stem Cells
por: Stoddard-Bennett, Theo, et al.
Publicado: (2019)

Human-Induced Pluripotent Stem Cell Technology: Toward the Future of Personalized Psychiatry
por: Alciati, Alessandra, et al.
Publicado: (2022)

A Comprehensive Library of Familial Human Amyotrophic Lateral Sclerosis Induced Pluripotent Stem Cells
por: Li, Ying, et al.
Publicado: (2015)

In vitro models of multiple system atrophy from primary cells to induced pluripotent stem cells
por: Abati, Elena, et al.
Publicado: (2018)

Transgene Reactivation in Induced Pluripotent Stem Cell Derivatives and Reversion to Pluripotency of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells
por: Galat, Vasiliy, et al.
Publicado: (2016)

Risk of Getting COVID-19 in People With Multiple Sclerosis: A Case-Control Study
por: Iaffaldano, Pietro, et al.
Publicado: (2022)

Generation of Induced Pluripotent Stem Cells from Patients with Multiple Myeloma
por: Yılmaz Başaran, İrem, et al.
Publicado: (2021)

A Personalized Approach in Progressive Multiple Sclerosis: The Current Status of Disease Modifying Therapies (DMTs) and Future Perspectives
por: D’Amico, Emanuele, et al.
Publicado: (2016)

Good multiple sclerosis (MS) care and how to get there in Canada: Perspectives of Canadian healthcare providers working with persons with MS
por: Petrin, Julie, et al.
Publicado: (2023)

Prediction Model of Amyotrophic Lateral Sclerosis by Deep Learning with Patient Induced Pluripotent Stem Cells
por: Imamura, Keiko, et al.
Publicado: (2021)

Investigating Pediatric Disorders with Induced Pluripotent Stem Cells
por: Durbin, Matthew D., et al.
Publicado: (2018)

Multiple Sclerosis, COVID-19 and Vaccines: Making the Point
por: Toscano, Simona, et al.
Publicado: (2021)

Effect of Exogenous Transcription Factors Integration Sites on Safety and Pluripotency of Induced Pluripotent Stem Cells
por: Yin, S, et al.
Publicado: (2020)

Reply: A South Asian Perspective to ‘Myths and Misconceptions Around Antibiotic Resistance: Time to Get Rid of Them’
por: Amábile-Cuevas, Carlos F.
Publicado: (2023)

Why monkeys do not get multiple sclerosis (spontaneously): An evolutionary approach
por: Bove, Riley M
Publicado: (2018)

An Integrated Miniature Bioprocessing for Personalized Human Induced Pluripotent Stem Cell Expansion and Differentiation into Neural Stem Cells
por: Lin, Haishuang, et al.
Publicado: (2017)

DNMT3B shapes the mCA landscape and regulates mCG for promoter bivalency in human embryonic stem cells
por: Tan, Hong Kee, et al.
Publicado: (2019)

C/EBPa controls acquisition and maintenance of adult hematopoietic stem cell quiescence
por: Ye, Min, et al.
Publicado: (2013)

Induced pluripotent stem cells for therapy personalization in pediatric patients: Focus on drug-induced adverse events
por: Genova, Elena, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_p8n7d8kip2f2e57qbj8ragl10g